Stephen Baxter

Q: What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of 90.63836093830189.

Q: What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of 9.554528774560831.

Wells Fargo | Healthcare

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #1562 out of 4548 analysts, they have issued 75 stock ratings with a success rate of 90.64% and an average return of 9.55%.

Stephen Baxter has a well-established track record, with 75 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.64% and an average return of 9.55%, underscoring their expertise and ability to identify winning opportunities for investors.

#1562

Out of 4548

Total Ratings

+90.64%

Success Rate

+9.55%

Average Return

Recent Ratings Analysis

MOH

Hold

Feb 20, 2026

Target

$208.00

Current

$151.00

Performance

0.00%

Stephen Baxter rated MOH as Equal-Weight on Feb 20, 2026, setting a price target of 208. The Hold stance appears justified, as shares hovered around 151 with a 0.00% move.

HUM

Hold

Feb 18, 2026

Target

$290.00

Current

$189.83

Performance

1.45%

On Feb 18, 2026, HUM was given a Equal-Weight rating by Stephen Baxter, with a target price of 290. Market indecision, reflected in sideways trading near 189.83, supported the cautious call.

CNC

Hold

Feb 18, 2026

Target

$44.00

Current

$43.24

Performance

0.39%

CNC received a Equal-Weight rating from Stephen Baxter on Feb 18, 2026, aiming for 44. Shares remained flat at 43.24, aligning with the neutral rating.

COR

Buy

Feb 10, 2026

Target

$429.00

Current

$361.08

Performance

0.30%

On Feb 10, 2026, Stephen Baxter published a Overweight outlook on COR, with a target of 429. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 361.08.

CAH

Buy

Feb 10, 2026

Target

$256.00

Current

$224.44

Performance

1.89%

Stephen Baxter on Feb 10, 2026 assigned CAH a Overweight rating, with a price target of 256. The recommendation remains pending validation as shares consolidate around 224.44.

MCK

Hold

Feb 05, 2026

Target

$925.00

Current

$947.48

Performance

-1.08%

On Feb 05, 2026, Stephen Baxter reaffirmed MCK with a Equal-Weight rating, targeting 925. The neutral call matched muted market action of -1.08%.

HCA

Hold

Jan 30, 2026

Target

$481.00

Current

$532.30

Performance

9.02%

HCA was rated Equal-Weight by Stephen Baxter on Jan 30, 2026, with a price objective of 481. Despite caution, upside momentum rewarded risk-takers with gains to 532.3.

UNH

Buy

Jan 30, 2026

Target

$370.00

Current

$290.00

Performance

1.07%

On Jan 30, 2026, Stephen Baxter initiated coverage on UNH with a Overweight rating and target of 370. Neutral price movement of 1.07% leaves room for interpretation.

ELV

Buy

Jan 30, 2026

Target

$391.00

Current

$342.93

Performance

-0.81%

Stephen Baxter issued a Overweight recommendation for ELV on Jan 30, 2026, price target set at 391. The target of 391 remains in play, though confirmation will depend on future moves.

MDLN

Hold

Jan 12, 2026

Target

$42.00

Current

$49.80

Performance

16.57%

On Jan 12, 2026, MDLN was evaluated by Stephen Baxter, who gave a Equal-Weight rating and target of 42. Investors who stayed in despite the Hold saw upside of 16.57%.

CYH

Sell

Jan 07, 2026

Target

$3.00

Current

$3.56

Performance

9.20%

Stephen Baxter rated CYH as Underweight on Jan 07, 2026, setting a price target of 3. The bearish call was validated, as shares fell 9.20% to 3.56.

THC

Buy

Jan 07, 2026

Target

$252.00

Current

$229.90

Performance

13.81%

On Jan 07, 2026, THC was given a Overweight rating by Stephen Baxter, with a target price of 252. The stock rallied 13.81% after the rating, narrowing the gap to the target of 252 and validating the bullish stance.

PNTG

Buy

Jan 07, 2026

Target

$38.00

Current

$32.32

Performance

11.83%

PNTG received a Overweight rating from Stephen Baxter on Jan 07, 2026, aiming for 38. Momentum has favored the Buy call, with shares climbing from 32.32 to 32.32, rewarding those who trusted the recommendation.

BTSG

Buy

Jan 07, 2026

Target

$43.00

Current

$41.06

Performance

3.92%

On Jan 07, 2026, Stephen Baxter published a Overweight outlook on BTSG, with a target of 43. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 41.06.

UHS

Hold

Jan 07, 2026

Target

$259.00

Current

$230.49

Performance

10.61%

Stephen Baxter on Jan 07, 2026 assigned UHS a Equal-Weight rating, with a price target of 259. Shares outperformed expectations, climbing 10.61% despite the neutral view.

CVS

Buy

Nov 13, 2025

Target

$102.00

Current

$76.69

Performance

-3.22%

On Nov 13, 2025, Stephen Baxter reaffirmed CVS with a Overweight rating, targeting 102. Market indecision has kept the 102 target in a holding pattern.

OSCR

Sell

Nov 13, 2025

Target

$11.00

Current

$13.23

Performance

-5.16%

OSCR was rated Underweight by Stephen Baxter on Nov 13, 2025, with a price objective of 11. The Sell stance proved too pessimistic given the -5.16% climb.

AGL

Buy

Nov 05, 2025

Target

$1.00

Current

$0.44

Performance

-41.92%

On Nov 05, 2025, Stephen Baxter initiated coverage on AGL with a Overweight rating and target of 1. The Buy call has yet to be validated as shares remain 0.56 away from the target.

CI

Hold

Nov 05, 2025

Target

$300.00

Current

$280.31

Performance

7.99%

Stephen Baxter issued a Equal-Weight recommendation for CI on Nov 05, 2025, price target set at 300. A neutral call gave way to stronger-than-expected performance, closing in on 300.

TDOC

Hold

Apr 29, 2024

Target

$15.00

Current

$4.74

Performance

-64.60%

On Apr 29, 2024, TDOC was evaluated by Stephen Baxter, who gave a Equal-Weight rating and target of 15. The Hold call avoided chasing into subsequent weakness of 64.60%.

Frequency Asked Questions

Who is Stephen Baxter?

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of +90.64%.

How many ratings has Stephen Baxter issued?

Stephen Baxter has issued 75 stock ratings so far.

What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of +9.55%.

What is Stephen Baxter's ranking?

Stephen Baxter is ranked #1562 out of 4548 analysts.

What types of ratings does Stephen Baxter give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Stephen Baxter?

You can follow Stephen Baxter by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Stephen Baxter?

Their latest rating was a Hold on MOH issued on 2026-02-20.